Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | M3T01 |
| Trade Name | |
| Synonyms | M 3T01|M-3T01 |
| Drug Descriptions |
Limited information is currently available on M3T01, a putative monoclonal antibody targeting FasL (Dec 2024). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fluorouracil + Leucovorin + M3T01 + Oxaliplatin + Pembrolizumab | Fluorouracil Leucovorin M3T01 Oxaliplatin Pembrolizumab | 0 | 1 |
| M3T01 | M3T01 | 0 | 1 |
| M3T01 + Pembrolizumab | M3T01 Pembrolizumab | 0 | 1 |
| M3T01 + Temozolomide | M3T01 Temozolomide | 0 | 1 |